Literature DB >> 8265772

Ocular manifestations of classical and limited Wegener's granulomatosis.

P Stavrou1, J Deutsch, C Rene, D E Laws, R A Luqmani, P I Murray.   

Abstract

Wegener's granulomatosis (WG) may be subdivided into two forms, classical and limited. The latter specifically excludes renal disease and carries a better prognosis. Both forms have sight-threatening complications, but the relative incidence of ocular manifestations in each is not well documented. Patients with limited (n = 15) and classical (n = 16) WG were ophthalmologically examined. Ocular abnormalities found included orbital and nasolacrimal disease, corneo-scleral inflammation, dry eyes and retinal vein occlusion. In four patients (two from each group), no ocular disease was detected. The limited group included four potentially sight-threatening complications, compared to eight in the classical group. Overall, there was no statistically significant difference in any of the ocular manifestations between the two groups. Although treatment with corticosteroid and immunosuppressive agents has dramatically improved the prognosis of the disease, ocular morbidity is still well recognized. A combined medical and ophthalmological approach with prompt therapeutic intervention is recommended in these patients.

Entities:  

Mesh:

Year:  1993        PMID: 8265772

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  10 in total

1.  Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.

Authors:  Cord Huchzermeyer; Christian Mardin; Leonard Holbach; Jochen Zwerina; Georg Schett; Jürgen Rech
Journal:  Clin Rheumatol       Date:  2010-09-23       Impact factor: 2.980

2.  Central retinal vein occlusion in Wegener's granulomatosis without retinal vasculitis.

Authors:  M Wang; R N Khurana; S R Sadda
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

Review 3.  Non-infectious orbital vasculitides.

Authors:  B Perumal; E H Black; F Levin; J J Servat
Journal:  Eye (Lond)       Date:  2012-02-24       Impact factor: 3.775

4.  Vasculitis and rapidly progressive glomerulonephritis in the elderly.

Authors:  R M Higgins; D J Goldsmith; J Connolly; J E Scoble; B M Hendry; P Ackrill; M C Venning
Journal:  Postgrad Med J       Date:  1996-01       Impact factor: 2.401

5.  Ophthalmic manifestations and visual outcomes of granulomatosis with polyangiitis: a retrospective multicentre study in Korea.

Authors:  Min Kyu Yang; Hye Won Kim; Eun Ha Kang; Namju Kim; Hokyung Choung; Sang In Khwarg
Journal:  Eye (Lond)       Date:  2022-05-28       Impact factor: 3.775

6.  Ocular and renal sarcoidosis.

Authors:  S Shah; M D Cole; A Nicholls
Journal:  J R Soc Med       Date:  1995-10       Impact factor: 5.344

7.  Cytomegalovirus retinitis treated with valganciclovir in Wegener's granulomatosis.

Authors:  Yoshiaki Kabata; Genichiro Takahashi; Hiroshi Tsuneoka
Journal:  Clin Ophthalmol       Date:  2012-03-27

8.  A young lady presented with limited pulmonary Wegener's granulomatosis.

Authors:  Atin Dey; Datta Chaudhuri Arunabha; Pandit Sudipta; Kundu Susmita; Saha Mita
Journal:  Lung India       Date:  2008-10

9.  Granulomatosis with polyangiitis presenting as a choroidal tumor.

Authors:  Taro Masuda; Yasumori Izumi; Hayato Takeshita; Chieko Kawahara; Yoshika Tsuji; Hirokazu Kurohama; Nozomi Iwanaga; Miwako Inamoto; Keiichi Kase; Masahiro Ito; Atsushi Kawakami; Kiyosi Migita
Journal:  Case Rep Rheumatol       Date:  2015-04-08

10.  Conjunctivitis as a manifestation of Wegener's Granulomatosis.

Authors:  Mahmoud Nejabat; Golnoush Sadat Mahmoudi Nezhad; Saeedeh Shenavandeh; Mohammad Javad Ashraf; Mohammad Hassan Jalalpour
Journal:  J Curr Ophthalmol       Date:  2017-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.